ADS News Release


State-of-the-art OxyBand™ Product To Revolutionize Healing For Injured Skin and Tissue

VIRGINIA BEACH, VA. March 30, 2016 – ADS, Inc. provides customized solutions to all branches of the military, first responders, law enforcement and government organizations. As a leader in the industry, ADS, Inc. seeks out manufacturers and partnerships that are on the cutting edge of technology in order to provide their customers with the best possible products to complete their missions.

Enter OxyBand™, cleared by the FDA to administer oxygen to wounds and tissue for up to 5 days directly from the dressing without a generator, tank or carrier solution. In a clinical trial conducted by the United States Army Institute for Surgical Research (USAISR), OxyBandsignificantly outperformed the standard of care for accelerating healing and reducing pain without infection.

PRESS CONTACT Mike Eyre 757-275-7971  |  meyre@adsinc.com

When tissues in the body are deprived of oxygen, the irreversible process of tissue death begins. For those on the front lines suffering burns, blasts and other injuries, damage can occur to tissue and blood vessels; interrupting the blood supply needed to deliver oxygen to the wound site for tissue regeneration. Thanks to this recent partnership, OxyBand™ will be on the battlefield, in the line of duty or in the wake of emergency when needed most.

In an effort to simplify and expedite the procurement process for their customers, ADS, Inc. has made OxyBand™ available on their Distribution and Pricing Agreement (DAPA) Schedule with DLA, and proofed the product to fit the scope of a variety of their other Indefinite Delivery, Indefinite Quantity (IDIQ) Contracts. ADS, Inc. is also stocking the product to minimize the delivery time for orders.


For more information about Oxyband and our Medical Solutions, contact your ADS Representative or visit our Medical page.

About ADS, Inc. ADS Inc. is a leading value-added logistics and supply chain solutions provider that proudly serves all branches of the U.S. Military, federal, state and local government organizations, law enforcement agencies, first responders, partner nations and the defense industry. ADS is a top 50 Department of Defense Federal Contractor and Gold Tier supplier for the Defense Logistics Agency. The company is focused on solving customers’ challenges by providing the best product and service offerings, the broadest array of procurement and contract options, world-class support and legendary customer service. To learn more, please visit the ADS website at www.adsinc.com.

About Oxyband Technologies Inc. OxyBand Technologies develops proprietary wound healing and regenerative medical technologies which provide oxygen and other therapeutic gases to wounds, skin and tissue. OxyBand is the first to develop and commercialize a sustained transdermal oxygen wound dressing, cleared by the FDA that provides pure oxygen to wounds for up to 5 days from a single dressing allowing for targeted oxygen delivery when and where it is needed. OxyBand Wound Dressing has been extensively tested in three clinical trials, including a multi-year prospective, randomized, controlled trial by the preeminent United States Army Institute of Surgical Research and published results which show OxyBand heals wounds significantly faster, with significantly less pain, without infection compared to standard care and placebo. OxyBand has a comprehensive patent portfolio of platform technologies focused on healing, tissue regeneration and therapeutic gases. The company was founded by scientists and engineers to develop the most effective, evidence based medical technologies to improve outcomes for wounded soldiers and patients around the world.